Cellectis (CLLS) EV to CFO (2015 - 2025)
Cellectis' EV to CFO came in at -4.64 for Q1 2025.
Powered by 
Analysis
Cellectis (CLLS) EV to CFO (2015 - 2025) Analysis & Trends
Over the trailing twelve months to Mar 31, 2025, Cellectis reported EV to CFO of -31.88; for FY2024, it was -3.49.
- Business Quant data shows CLLS's EV to CFO at -3.49 (Q4 2024), -0.78 (Q3 2024) and -1.55 (Q2 2024) in the three quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Cellectis | 147.50 Mn | -605.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -4.64 |
| Dec 31, 2024 | -3.49 |
| Sep 30, 2024 | -0.78 |
| Jun 30, 2024 | -1.55 |
| Dec 31, 2015 | 223.51 |
API Access
Cellectis EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();